| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/31/2009 | US7511072 7-amido-isoindolyl compounds and methods of its use |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | US7511049 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent, viricide; breast canceer, arthritis, Alzheimer's disease, cardiovascular diseases, with other active compounds |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511043 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids |
| 03/31/2009 | US7511031 Transcutaneous photodynamic therapy; patch placed over target tissue; liposomal, transdermal, iontophoretic photosensitizing agent; light emitting diodes; atherosclerotic lesions and restenotic lesions |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511023 adriamycin; chemotherapy; sustained release |
| 03/31/2009 | US7510870 STAT3 activated stem cell |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510830 Cancer treatment by combination therapy |
| 03/31/2009 | US7510826 Process for the depletion or removal of endotoxins |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510700 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/31/2009 | CA2396734C Extraction of flavonoids |
| 03/31/2009 | CA2356959C Water-insoluble drug delivery system |
| 03/31/2009 | CA2294502C Use of intravenous contrast media for projection mammography |
| 03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
| 03/31/2009 | CA2193627C Subcutaneous implant |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/28/2009 | CA2640655A1 Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma vaccination |
| 03/26/2009 | WO2009039397A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer |
| 03/26/2009 | WO2009039387A1 Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof |
| 03/26/2009 | WO2009039337A2 Inhibition of angiogenesis |
| 03/26/2009 | WO2009039199A2 Compositions comprising stat5 sirna and methods of use thereof |
| 03/26/2009 | WO2009039189A2 Compositions comprising stat3 sirna and methods of use thereof |
| 03/26/2009 | WO2009038879A2 Stem cell differentiating agents and uses therefor |
| 03/26/2009 | WO2009038779A2 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents |
| 03/26/2009 | WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 03/26/2009 | WO2009038757A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 03/26/2009 | WO2009038745A1 Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion |
| 03/26/2009 | WO2009038701A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 03/26/2009 | WO2009038683A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009038026A1 Ctl inducer composition |
| 03/26/2009 | WO2009037857A1 Diagnostic agent and therapeutic agent for lung cancer, prostate cancer, breast cancer, ovarian cancer or melanoma |
| 03/26/2009 | WO2009037705A2 Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation |
| 03/26/2009 | WO2009037525A1 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and use thereof |
| 03/26/2009 | WO2009037512A1 Therapeutic methods 013 |
| 03/26/2009 | WO2009037467A1 Pyrrolopyrimidine compounds |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009037343A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | WO2009037308A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | WO2009037225A2 Production of leaf extracts of pittosporum phillyraeoides and the use thereof in medicine |
| 03/26/2009 | WO2009037001A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 03/26/2009 | WO2009036772A1 Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
| 03/26/2009 | WO2009036753A2 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy |
| 03/26/2009 | WO2009036656A1 Coumarin derivatives, preparation processes and uses thereof |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009036574A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 03/26/2009 | WO2009036568A1 Methods and compositions for treating tumors and viral infections |
| 03/26/2009 | WO2009022897A3 Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal |
| 03/26/2009 | WO2009020964A3 Anti-neublastin antibodies and uses thereof |
| 03/26/2009 | WO2009020933A3 Therapeutic use of anti-tweak receptor antibodies |
| 03/26/2009 | WO2009020631A3 Compounds for treating proliferative disorders |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009015368A3 Multikinase inhibitors for use in the treatment of cancer |
| 03/26/2009 | WO2009007753A3 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2009001209A8 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | WO2008074488A3 Construction and use of transfection enhancer elements |
| 03/26/2009 | WO2008058269A3 Compounds and methods for modulating protein trafficking |
| 03/26/2009 | WO2008039525A3 Cadherin antagonists in combination with anticancer agents for use in cancer treatment |
| 03/26/2009 | WO2008010101A8 Antagonist antibody against epha2 for the treatment of cancer |
| 03/26/2009 | WO2005084295A3 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082446 Use of Hydroxyoleic acid and related compounds in the manufacture of drugs |
| 03/26/2009 | US20090082445 Gossypol co-crystals and the use thereof |
| 03/26/2009 | US20090082444 Compositions for the Treatment of Blood Disorders |
| 03/26/2009 | US20090082438 Coordination Compound Composed of Diaminocyclohexane Platinum (II) and Block Copolymer and Anti-Cancer Agent Comprising the Same |
| 03/26/2009 | US20090082437 Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082425 Compounds from myrothecium sp. for inhibiting the growth of cancer cells |
| 03/26/2009 | US20090082424 Small molecule antagonists of bcl-2 family proteins |
| 03/26/2009 | US20090082413 Deuterium-enriched letrozole |
| 03/26/2009 | US20090082408 Novel heterocyclic derivatives |
| 03/26/2009 | US20090082406 Cancer Therapy |
| 03/26/2009 | US20090082379 Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082375 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 03/26/2009 | US20090082374 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 03/26/2009 | US20090082370 Pharmaceutical Combinations of PK Inhibitors and Other Active Agents |
| 03/26/2009 | US20090082349 Thiazolones for use as pi3 kinase inhibitors |
| 03/26/2009 | US20090082348 Indazole derivatives |
| 03/26/2009 | US20090082346 Substituted Pyrrolo-Pyrazole Derivatives as Kinase Inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082332 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/26/2009 | US20090082324 Bifunctional Resorcinol, Thioresorcinol, and Dithioresorcinol Derivative Metal Chelating Conjugates |
| 03/26/2009 | US20090082323 Deuterium-enriched fulvestrant |